Hiperinsulinismo endógeno por insulinoma. A propósito de un caso

  1. Herranz-Antolín, Sandra 1
  2. Serrano-Martínez, Alberto 2
  3. Álvarez-de Frutos, Visitación 1
  4. Candia-Fernández, Antonio 3
  1. 1 Servicio de Endocrinología y Nutrición, Hospital Universitario de Guadalajara, Guadalajara, España
  2. 2 Servicio de Medicina Interna, Hospital Universitario de Guadalajara, Guadalajara, España
  3. 3 Servicio de Anatomía Patológica, Hospital Universitario de Guadalajara, Guadalajara, España
Zugehörigkeit anzeigen +
Zeitschrift:
Revista Española de Casos Clínicos en Medicina Interna (RECCMI)

ISSN: 2530-0792

Datum der Publikation: 2017

Titel der Ausgabe: Spanish Journal of Case Records in Internal Medicine

Ausgabe: 2

Nummer: 2

Seiten: 71-73

Art: Artikel

DOI: 10.32818/RECCMI.A2N2A4 DIALNET GOOGLE SCHOLAR lock_openOpen Access editor

Andere Publikationen in: Revista Española de Casos Clínicos en Medicina Interna (RECCMI)

Ziele für nachhaltige Entwicklung

Zusammenfassung

A 61 year-old woman was referred to Endocrinology department for the study of dizziness episodes without the sensation of spinning objets, as well as nervousness, palpitations and tremors. All of which improved after intake of carbohydrates. After a clinical suspicion of hypoglycemia and the complementary tests were performed, the patient was diagnosed with endogenous hyperinsulinism. The possibility of factitious hypoglycemias was dismissed. An endoscopic ultrasonography was performed, through which a pancreatic insulinoma was diagnosed that was non-visible on computed tomography. Finally, an enucleation of the lesion was performed, after which the clinical symptomatology was resolved. The patient remains asymptomatic at the present time.

Bibliographische Referenzen

  • Cryer P, Axelrod L, Grossman A. Evaluation and management of adult hypoglycemic disorders: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2009; 94: 709-28.
  • Palomares R, Zurera L, Gálvez MA, Tofe S, Canis M, Benito P. Utilidad de la arteriografía con inyección intraarterial selectiva de calcio en el diagnóstico del insulinoma. Med Clin (Barc). 2002; 119: 568-70.
  • Diéguez M, Riestra M, Menéndez E. Insulinoma: criterios diagnósticos y tratamiento. Av Diabetol. 2009; 25: 293-9.
  • Kimberly A, Placzkowsky K, Vella A. Secular trends in the presentation and management of functioning insulinoma at the Mayo Clinic, 1987-2007. J Clin Endocrinol Metab. 2009; 94: 1069-1073.
  • Dizon AM, Kowalyk S, Hoogwerf BJ. Neuroglycopenic and other symptoms in patients with insulinomas. Am J Med. 1999; 106: 307-10.
  • Guettier JM, Kam A, Chang R, Skarulis MC, Cochran C, Alexander HR. Localization of insulinomas to regions of the pancreas by intraarterial calcium stimulation: the NIH Experience. J Clin Endocrinol Metab. 2009; 94: 1074-80.
  • Bassam A, Joe B. Occult sporadic insulinoma. Localization and surgical strategy. World J Gastroenterol. 2008; 14: 657-665.
  • Kauhanen S, Seppänen M, Minn H, Gullichsen R, Salonen A, Alanen K. Fluorine-18-L-dihydroxyphenylalanine (18F-DOPA) positron emission tomography as a tool to localize an insulinoma or ß-cell hyperplasia in adult patients. J Clin Endocrinol Metab. 2009; 92: 1237-44.
Fuente de los datos: Dialnet